FDA approves Ofev® as the first and only therapy to slow the rate of decline in pulmonary function …

… abdominal pain, liver enzyme elevation, weight decreased, fatigue, decreased appetite, headache, fever, back pain, dizziness and hypertension.
Source: back pain